She continues, "The cardiovascular protection and other emerging benefits, such as improvements in outcomes related to metabolic-associated liver disease and obstructive sleep apnea, are additional benefits of these medications." About the Author Jennifer Fisher, MMSc, PA-C, Health Writer About the Reviewer Chika V
[DOI] [PMC free article] [PubMed] [Google Scholar] 117.Masisi B.K., El Ansari R., Alfarsi L., Craze M.L., Jewa N., Oldfield A., Cheung H., Toss M., Rakha E.A., Green A.R
Before starting treatment, a healthcare provider will conduct a comprehensive assessment, reviewing medical history, current medications, weight loss goals, and overall health to determine if Semaglutide GLP-1 is suitable
The first is the GLP-1 receptor , which most people recognize from semaglutide and other incretin-based therapies